Tag:
Nivestim
Latest Headlines
Latest Headlines
Hospira gains EMA OK for Neupogen biosimilar
Hospira says that it won European approval for its follow-on therapy to Amgen's blockbuster Neupogen. In winning the OK, Hospira provided late-stage data demonstrating that its therapy, Nivestim
